Retrospective Study on Trilostane Titration Dose Treatment in Dogs with Terminal Stage of Hyperadrenocorticism
References
- Feldman, E.C., Nelson, R.W. (2004). Canine hyperadrenocorticism Cushings syndrome. In: Canine and Feline Endocrinology and Reproduction (p. 252). Elsevier Health Sciences.
- Kritsepi-Konstantinou, M., Oikonomidis, I.L. (2016). The interpretation of leukogram in dog and cat. HJCAM 5(2): 63.
- Ryad, N.M., Ramadan, E.S., Salem, N.Y., Saleh, I.A. (2021). Influence of dexamethasone administration on hematology, biochemistry, and thyroid hormones in dogs. Adv Anim Vet Sci. 9(1): 111-116. https://doi.org/10.17582/journal.aavs/2021/9.1.111.116
- Peterson, M.E. (2007). Diagnosis of hyperadrenocorticism in dogs. Clin Tech Small Anim Pract. 22(1): 2-11. https://doi.org/10.1053/j.ctsap.2007.02.007 PMid:17542191
- Behrend, E.N., Kooistra, H.S., Nelson, R., Reusch, C.E., Scott‐Moncrieff, J.C. (2013). Diagnosis of spontaneous canine hyperadrenocorticism: 2012 ACVIM consensus statement (small animal). J Vet Intern Med. 27(6): 1292-1304. https://doi.org/10.1111/jvim.12192 PMid:24112317
- Potts, G.O., Creange, J.E., Harding, H.R., Schane, H.P. (1978). Trilostane, an orally active inhibitor of steroid biosynthesis. Steroids 32(2): 257-267. https://doi.org/10.1016/0039-128X(78)90010-7 PMid:715820
- Eastwood, J.M., Elwood, C.M., Hurley, K.J. (2003). Trilostane treatment of a dog with functional adrenocortical neoplasia. J Small Anim Pract. 44(3): 126-131. https://doi.org/10.1111/j.1748-5827.2003.tb00133.x PMid:12653328
- Neiger, R., Hurley, K.J., Ramsey, I., O’Connor, J., Mooney, C.T. (2002). Trilostane treatment of 78 dogs with pituitary‐dependent hyperadrenocorticism. Vet Rec. 150(26): 799-804. https://doi.org/10.1136/vr.150.26.799 PMid:12120922
- Lemetayer, J., Blois, S. (2018). Update on the use of trilostane in dogs. Can Vet J. 59(4): 397-407.
- Bell, R., Neiger, R., McGrotty, Y., Ramsey, I.K. (2006). Study of the effects of once daily doses of trilostane on cortisol concentrations and responsiveness to adrenocorticotrophic hormone in hyperadrenocorticoid dogs. Vet Rec. 159(9): 277-281. https://doi.org/10.1136/vr.159.9.277 PMid:16946310
- Vaughan, M.A., Feldman, E.C., Hoar, B.R., Nelson, R.W. (2008). Evaluation of twice-daily, low-dose trilostane treatment administered orally in dogs with naturally occurring hyperadrenocor ticism. J Am Vet Med Assoc. 232(9): 1321-1328. https://doi.org/10.2460/javma.232.9.1321 PMid:18447776
- Feldman, E.C. (2011). Evaluation of twice-daily lower-dose trilostane treatment administered orally in dogs with naturally occurring hyperadrenocorticism. J Am Vet Med Assoc. 238(11): 1441-1451. https://doi.org/10.2460/javma.238.11.1441 PMid:21627507
- Teshima, T., Hara, Y., Takekoshi, S., Nezu, Y., Harada, Y., Yogo, T., Teramoto, A., Osaamura, R.Y., Tagawa, M. (2009). Trilostane-induced inhibition of cortisol secretion results in reduced negative feedback at the hypothalamic-pituitary axis. Domest Anim Endocrinol. 36(1): 32-44. https://doi.org/10.1016/j.domaniend.2008.10.002 PMid:19041802
- Gilor, C., Graves, T.K. (2011). Interpretation of laboratory tests for canine Cushing’s syndrome. Top Companion Anim Med. 26(2): 98-108. https://doi.org/10.1053/j.tcam.2011.03.001 PMid:21596349
- Fathman, L. (2005). Textbook of veterinary internal medicine. Elsevier Saunders
- Jacoby, R.C., Owings, J.T., Ortega, T., Gosselin, R., Feldman, E.C. (2001). Biochemical basis for the hypercoagulable state seen in Cushing syndrome; discussion 1006-7. Arch Surg. 136(9): 1003-1006. https://doi.org/10.1001/archsurg.136.9.1003 PMid:11529821
- Galac, S. (2010). Recent developments in canine Cushings syndrome. Utrecht University
- Cho, K.D., Kang, J.H., Chang, D., Na, K.J., Yang, M.P. (2013). Efficacy of low‐ and high‐dose trilostane treatment in dogs (<5 kg) with pituitary‐dependent hyperadrenocorticism. J Vet Intern Med. 27(1): 91-98. https://doi.org/10.1111/jvim.12007 PMid:23167780
- Ettinger, S.J., Feldman, E.C. (2010). Textbook of veterinary internal medicine. 7th edition, 2086-2088.
- Alenza, D.P., Arenas, C., Lopez, M.L., Melian, C. (2006). Long-term efficacy of trilostane administered twice daily in dogs with pituitary-dependent hyperadrenocorticism. J Am Anim Hosp Assoc. 42(4): 269-276. https://doi.org/10.5326/0420269 PMid:16822765
DOI: https://doi.org/10.2478/macvetrev-2024-0016 | Journal eISSN: 1857-7415
Language: English
Page range: 51 - 57
Submitted on: Jan 16, 2024
Accepted on: Feb 20, 2024
Published on: Mar 1, 2024
Published by: Ss. Cyril and Methodius University in Skopje
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2024 Irena Celeska, Martin Nikolovski, Todor Novakov, Anastasija Angelovska, Ivica Gjurovski, Elena Atanaskova Petrov, published by Ss. Cyril and Methodius University in Skopje
This work is licensed under the Creative Commons Attribution 4.0 License.